InvestorsHub Logo
Post# of 312684
Next 10
Followers 97
Posts 128742
Boards Moderated 1
Alias Born 07/24/2016

Re: None

Wednesday, 04/18/2018 3:05:32 PM

Wednesday, April 18, 2018 3:05:32 PM

Post# of 312684

$BCTXF an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce that it has presented two posters highlighting its most recent scientific and clinical findings of BriaCell’s lead product candidate, SV-BR-1-GM, also known as Bria-IMT™, at the 2018 American Association of Cancer Research (AACR) Annual Meeting. The posters are available for viewing at http://briacell.com/category/recent-events/.

News: BriaCell Provides Highlights of Scientific and Clinical Findings at AACR https://finance.yahoo.com/news/briacell-provides-highlights-scientific-clinical-133000708.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.